Novartis Pharmaceuticals Corporation to Appeal Judgment in Alabama Pricing Case
Novartis Pharmaceuticals Corporation (NPC) announced it will appeal a verdict in the Montgomery County Circuit Court. Novartis disputes the State of Alabama's claims that the prices provided by NPC to reporting services resulted in overpayment to pharmacists and doctors in the Alabama State Medicaid system.
Read more ...
Shire proposes acquisition of Jerini AG for an equity purchase price of €328 million
Shire Limited (LSE: SHP, NASDAQ: SHPGY), the global specialty biopharmaceutical company, announced that Maia Elfte Vermögensverwaltungs-GmbH, to be renamed "Shire Deutschland Investments GmbH", a German indirect subsidiary of Shire Limited, will launch a voluntary public takeover offer for shares in Jerini AG (FSE:JI4, ISIN: DE0006787476), the publicly listed German biotechnology company.
Read more ...
Summary Judgment Granted for SEROQUEL Patent Litigation in the US
AstraZeneca announced that the US District Court for the District of New Jersey has granted the company's Motion for Summary Judgment of No Inequitable Conduct. AstraZeneca had sued Teva Pharmaceutical Industries Ltd. and Sandoz, Inc. alleging infringement of AstraZeneca's patent as a result of Teva's and Sandoz's filings of Abbreviated New Drug Applications (ANDAs).
Read more ...
GlaxoSmithKline responds to FDA on Cervarix® and plans to submit final study data for approval
GlaxoSmithKline provided the following update regarding its application to the U.S. Food and Drug Administration (FDA) for approval of Cervarix®, its vaccine to prevent cervical cancer.
Read more ...
Novartis Institute for Tropical Diseases and Global Alliance for TB Drug Development
The Novartis Institute for Tropical Diseases (NITD) and the Global Alliance for TB Drug Development (TB Alliance) announced a five-year research collaboration designed to yield new medicines for TB, including drug-resistant TB.
Read more ...
Roche's tender offer to increase ownership stake in Chugai successful
Roche announced that its ownership stake in Chugai will increase from 50.1% to 59.9% following the successful completion of the tender offer which started on 23 May. Chugai shareholders had the opportunity to tender their shares at a price of Yen 1,730 per share, which reflects a premium of 11.7% over Chugaiâs share price of Yen 1,549 at the close of trading on 21 May 2008.
Read more ...
Abbott and Partnership for a Drug-Free America Launch 'Not In My House'
A house is the one place where a family should feel safe and secure, yet it is here that teens are prone to get prescription drugs to misuse and abuse. To help prevent teen prescription drug misuse and abuse, the Partnership for a Drug-Free America(R) and Abbott today launched "Not In My House", a national education initiative that provides parents with useful information and tips to help them limit teen access to medicines.
Read more ...